GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
1

160 Health International 2656.HK · HKD

N/A · HKEX · 🇭🇰 Hong Kong

Compare

3.46

-1.98%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥651.9m

FY2022FY2025

Net income

−CN¥73.0m

FY2022FY2025

Free cash flow

−CN¥118.6m

FY2022FY2025

Shareholders' equity

CN¥239.0m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
RevenueCN¥651.9mCN¥620.7mCN¥628.6mCN¥525.6m
Gross profitCN¥170.2mCN¥160.2mCN¥137.3mCN¥118.3m
Research and developmentCN¥35.0mCN¥57.1mCN¥50.6mCN¥59.6m
Operating income−CN¥63.3m−CN¥104.6m−CN¥99.5m−CN¥79.2m
Net income−CN¥73.0m−CN¥107.7m−CN¥108.8m−CN¥111.3m
Diluted earnings per share-0.22-0.32-0.32-0.33

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assetsCN¥759.9mCN¥297.8mCN¥236.2mCN¥178.9m
Cash and short-term investments—CN¥58.3mCN¥57.6mCN¥37.7m
Total liabilitiesCN¥525.8mCN¥382.9mCN¥273.9mCN¥562.9m
DebtCN¥2.9mCN¥13.2mCN¥17.5mCN¥7.5m
Shareholders' equityCN¥239.0m−CN¥85.1m−CN¥37.7m−CN¥384.0m
Shares outstanding336m336m336m336m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operations−CN¥114.4m−CN¥56.0m−CN¥64.5m−CN¥42.4m
Capital spending−CN¥4.2m−CN¥942,000−CN¥2.8m−CN¥2.5m
Free cash flow−CN¥118.6m−CN¥57.0m−CN¥67.3m−CN¥44.9m

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Jun 2024Mar 2024
RevenueCN¥190.2mCN¥100.5mCN¥620.7mCN¥179.7mCN¥94.2m
Gross profitCN¥36.2mCN¥27.9mCN¥160.2mCN¥38.1mCN¥24.5m
Operating income−CN¥1.1m−CN¥15.7m−CN¥104.6m−CN¥41.2m−CN¥39.1m
Net income−CN¥3.6m−CN¥15.5m−CN¥107.7m−CN¥44.1m−CN¥38.5m
Diluted earnings per share-0.01-0.05-0.32-0.13-0.11
Cash from operationsCN¥7.0m−CN¥13.0m−CN¥56.0m−CN¥10.0m−CN¥30.0m
Total assetsCN¥304.1mCN¥306.1m———
Cash and short-term investments—CN¥68.4m———
DebtCN¥275,000CN¥8.5m———
Shareholders' equity−CN¥94.3m−CN¥92.8m———

Financial ratios

Data as of 28 Sept 2026

FY2025FY2024FY2023FY2022
Gross margin26.1%25.8%21.8%22.5%
Operating margin-11.4%-16.9%-15.8%-15.1%
Net margin-11.2%-17.3%-17.3%-21.2%
Return on equity-30.5%126.5%288.3%29.0%
Return on assets-9.6%-36.2%-46.1%-62.2%
Free cash flow yield-8.9%———
Revenue growth5.0%-1.3%19.6%—
Earnings growth-32.2%-1.0%-2.2%—
Current ratio1.40x0.74x0.81x0.29x
Debt to equity0.01x-0.01x-0.01x-0.00x
Equity ratio31.5%-28.6%-16.0%-214.6%
Interest coverage-11.93x-250.30x-301.58x-1.97x
R&D as a share of sales5.4%9.2%8.0%11.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.1%——
Operating income-7.2%——
Net income-13.1%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.0%24.1%——

Valuation history

At each fiscal year end

FY2025
Price to earnings-220.8
Price to sales25.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.